We examined the course and predictors of postpartum depression in the 18 months following interpersonal psychotherapy (IPT). Method: We enrolled 120 community women with major depression in a 12-week randomized trial of individual IPT during the postpartum period (O'Hara, Stuart, Gorman, & Wenzel, 2000) . At 6, 12, and 18 months posttreatment, women participated in clinical interviews to establish the course of depression over the previous 6 months. We used survival analyses to characterize recovery and recurrence in the follow-up and growth curve modeling techniques to identify predictors of change in depression during the follow-up period. Potential predictors included severity, chronicity, and personal history of depression. Results: Of 35 women who recovered with acute treatment, 20 (57%) achieved sustained recovery during follow-up; average time to recurrence was 33.40 weeks (SD ϭ 18.43 weeks). Over 80% of women who did not recover with acute treatment experienced recovery at some point during follow-up; average time to recovery was 28.60 weeks (SD ϭ 17.51 weeks). Time depressed each month decreased over the follow-up period. Posttreatment depressive severity and length of the index episode predicted changes in depression over time. Posttreatment depression severity, personal history of depression, and weeks of treatment in the follow-up were significant predictors of time depressed during follow-up. Conclusions: IPT resulted in long-term benefits past the termination of acute treatment, even for women who did not initially recover. Though the vast majority of women who did not recover with acute treatment did recover during the follow-up period, continuation of IPT may accelerate the process.
The short-term efficacy of psychological treatments for postpartum depression has been well-established (Cooper, Murray, Wilson, & Romaniuk, 2003; O'Hara et al., 2000) . The long-term outcomes for treated postpartum women are not well characterized. The lack of research in this area is significant because the postpartum period presents significant challenges to women as they add the burden of infant care to their existent responsibilities in the home and at work. These challenges may undermine the sustainability of recovery or delay recovery for women who have not recovered by the end of treatment. Cooper et al. (2003) found that the effects of treatment (compared with usual care) had faded within about 5 months. No study has reported on recurrence and recovery rates in the context of long-term follow-up of treated postpartum depressed women.
Depression runs a chronic course (Solomon et al., 2000) ; relapse and recurrence rates following treatment are high and are similar across types of psychotherapy. A recent metaanalysis (Vittengl, Clark, Dunn, & Jarrett, 2007) found that among responders to cognitive behavior therapy, 29% experienced a relapse or recurrence by the end of the first year following treatment, and 54% experienced a relapse or recurrence by the end of the second year. Data from the National Institute of Mental Health Treatment of Depression Collaborative Research Program reported similar findings; rates of relapse for cognitive behavior therapy and interpersonal psychotherapy (IPT) were 36% and 33%, respectively, during an 18-month follow-up (Shea et al., 1992) .
Our first aim in this study was to establish the recurrence rate over an 18-month period for postpartum depressed women who had recovered with IPT (Klerman, Weissman, Rounsaville, & Chevron, 1984) and to establish the recovery rate for postpartum depressed women who had not recovered by the end of treatment. We expected that the proportion of time each month that women were clinically depressed would gradually decline because we expected women to continue to utilize skills learned in therapy. We also predicted that women who recovered with treatment would be less likely to seek additional treatment in the follow-up period than women who did not recover with treatment.
Depression-related variables at the time of acute treatment appear to be the most reliable predictors of long-term outcome (Szadoczky, Rozsa, Zambori, & Furedi, 2004) . We chose the number of past episodes of major depression and three indices of severity of episode (pretreatment and posttreatment depression severity and length of the index episode) and predicted that each of these variables would be positively associated with proportion of time depressed in the follow-up period. Additionally, if nonrecovered women (at the end of acute treatment) showed a trend toward recovery during the follow-up period, we predicted that higher levels of depression severity (pretherapy and posttherapy) should be associated with steeper declines in proportion of time depressed each month.
Method

Participants and Procedures
Participants and procedures are described in more detail elsewhere (O'Hara et al., 2000) . All procedures were approved by the University of Iowa Institutional Review Board. Participants were 120 women identified from state birth records. Women who met eligibility criteria (O'Hara et al., 2000) were given a demographic interview and screened for depression with the Inventory to Diagnose Depression (Zimmerman & Coryell, 1987) . Women who met this inventory's criteria for depression, who were in stable relationships, and who were not receiving treatment completed a telephone interview comprising the Structured Clinical Interview for DSM-IV (First, Spitzer, Gibbon, & Williams, 1997 ) and the Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960) . Women who met criteria for a major depressive episode and had scores greater than or equal to 12 on the 17-item version of the HRSD were invited to participate in the treatment phase.
Of the 345 women who met major depressive episode criteria on the initial telephone Structured Clinical Interview for DSM-IV, 77 met exclusion criteria of (a) lifetime history of bipolar disorder, schizophrenia, organic brain syndromes, or antisocial personality disorder; (b) current substance abuse, panic, obsessivecompulsive, eating, somatization, or psychotic disorders; or (c) three or more schizotypal features. Many women (n ϭ 132) declined the treatment study, overwhelmingly citing lack of time as the reason. Women were randomized into the individual IPT (n ϭ 60) or waiting list control (WLC; n ϭ 60) conditions ( Figure  1 ). All participants but one identified themselves as White, nonHispanic. Treatment began when infants were approximately 6 months of age (M ϭ 6.1 months, SD ϭ 0.7). Women in the IPT condition (n ϭ 60) received twelve 1-hr sessions over a 12-week period, delivered by doctoral-level psychologists. After a 12-week waiting period, women in the WLC group (n ϭ 60) received 12 sessions of IPT. A total of 12 women from IPT (20%) and nine from WLC (15%) dropped out during the acute phase. Women in both groups participated in follow-up assessments of psychopathology and additional treatment through 18 months posttreatment. Women were free to seek psychological or pharmacological treatment following the acute treatment phase.
Measures
Sociodemographic information. Through a telephone interview, participants provided information about themselves and their partners on sociodemographic variables.
Structured Clinical Interview for DSM-IV (First et al., 1997). This interview was used to assess symptom criteria for mood and anxiety disorders according to the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV;
American Psychiatric Association, 1994). Psychotic, antisocial, and schizotypal features were assessed with the Structured Clinical Interview for DSM-IV Personality Disorders (SIDP-IV; Pfohl, Blum, & Zimmerman, 1997) . The interview took approximately 45 to 90 min and was conducted by master'slevel research assistants. Interviewers were trained to reliability with a master coder (Laura Gorman; ϭ 0.93). Kappa ranged from 0.88 to 1.00 across all interviewer pairs.
HRSD (Hamilton, 1960) . The HRSD is a clinician-rated measure of depressive symptoms over the past week. The HRSD was administered pretreatment, at 4 and 8 weeks, and posttreatment (12 weeks). The HRSD was not utilized during the naturalistic followup. The intraclass correlation for the HRSD was .93, which is Longitudinal Interval Follow-Up Evaluation (LIFE; Keller et al., 1987) . The LIFE is a semistructured interview that retrospectively assesses psychopathology, functioning, and treatment for psychological and medical problems over a 6-month period. The LIFE was conducted 6, 12, and 18 months posttreatment. Women were asked a series of questions by trained interviewers to establish timing and severity of symptoms. The LIFE rating scale was modified to reflect whether participants met subthreshold or full DSM-IV criteria for depression. Intraclass correlations between raters for the week-by-week psychiatric status ratings for the major affective disorders were at least .90.
Beck Depression Inventory (Beck & Steer, 1987) . The Beck Depression Inventory is a 21-item self-report measure of depressive symptoms administered pretreatment, at 4 and 8 weeks, and on conclusion of treatment at 12 weeks.
Statistical Analyses
The 18-month follow-up period yielded a total of 78 weekly ratings of psychopathology, which were aggregated into 18 monthly composite variables reflecting the proportion of time during the month a woman was depressed (subthreshold or full criteria were weighted equally). For predictor analyses, scores on the Beck Depression Inventory and the HRSD were converted to z scores and added together to create a composite measure of depression severity pretreatment and posttreatment.
Analyses were conducted with SPSS, growth curve modeling techniques (Raudenbush & Bryk, 2002) , and the HLM 6 computer program (Raudenbush, Bryk, & Congdon, 2004) .Women who dropped out and did not provide any predictor or follow-up data (n ϭ 15) were dropped from analyses. Tables 1, 2 , and 3 contain a summary of participants' demographic and clinical characteristics. Ninety-nine women provided enough data to determine recovery and recurrence during the follow-up period (Table 3) . Recovery was defined as 8 consecutive weeks of sustained remission from depressive symptoms as measured by the LIFE. Recurrence was defined as symptoms of major depressive disorder meeting full criteria for at least 2 consecutive weeks, which occurred following a complete recovery (Frank et al., 1991) .
Results
Recurrence and Recovery During the Follow-Up
Kaplan-Meier survival curves presenting the cumulative proportion of recovered women remaining well and the cumulative proportion of nonrecovered women experiencing a recovery are shown in Figures 2A and 2B . Among the 35% of women who recovered with treatment (N ϭ 35), 15 (43%) women experienced a recurrence, principally between 10 and 50 weeks posttreatment. Among the 65% of women who were not recovered with treatment (N ϭ 64), 54 (84.4%) women recovered, most between 10 and 35 weeks in the follow-up period. Treatment seeking in the follow-up period did not significantly impact recovery among nonrecovered women 2 (1) ϭ 0.85, p ϭ .357; however, recovered women who did not seek treatment during follow-up remained well significantly longer (M ϭ 64.19 weeks; SE ϭ 9.26) than recovered women who did seek treatment (M ϭ 43.56 weeks; SE ϭ 4.22), 2 (1) ϭ 4.23, p ϭ .04.
Growth Curve Analyses
Changes in depression over 18 months posttreatment. We tested the following linear model: Y ij ( proportion of time depressed) ϭ ␤ 0j ϩ ␤ 1j (time)ϩ r ij , where Y ij is the proportion of time individual j met subthreshold or threshold criteria for major depression over the 1-month period prior to Time i, ␤ 0j is the intercept of individual j at Time 0 (i.e., the overall proportion of time depressed across 18 months), ␤ 1j is the rate of linear change in proportion of time depressed for individual j over time (i.e., slope), and r ij is the residual variance in repeated measures for individual j, which is assumed to be independent and normally distributed. The linear model was compared with a mean-andvariance model (i.e., in which proportion of time depressed is modeled as fluctuating randomly around an individual's mean): Y ij ( proportion of time depressed) ϭ ␤ 0j ϩ r ij . Time was measured in months since the midpoint between 1-month posttreatment and 18 months posttreatment and was group-mean centered at Level 1.
1
Relative to a mean-and-variance model, a linear model provided a better fit for the data, 2 (2) ϭ 544.29, p Ͻ .001. On average, proportion of time women were depressed decreased over the 18 months following treatment termination, t(119) ϭ Ϫ4.98, p Ͻ .001 (Figure 3 ). There was significant between-subjects variability in parameters for intercepts, 2 (102) ϭ 2,730.12, p Ͻ .001, and slopes, 2 (102) ϭ 869.66, p Ͻ .001. What accounts for trajectories of depression over the follow-up period? Group assignment was not a significant predictor of overall time depressed or changes in time depressed during the 18-month follow-up period; IPT and WLC groups were combined for the analyses. Predictors were grand-mean centered at Level 2 of the linear model (specified in Aim 1): ␤ 0j (intercept) ϭ ␥ 00 ϩ ␥ 01 ( predictor) ϩ 0j and ␤ 1j (time) ϭ ␥ 10 ϩ ␥ 11 ( predictor) ϩ 1j . Results (Table 4) indicate that greater symptom severity at the end of the treatment phase (but not at the beginning) was associated with a steeper decline in the proportion of time depressed over the 18-month follow-up period. A longer index episode of major depressive episode was associated with less linear decline over time. Posttreatment depression severity, a greater number of past major depressive episodes, and more weeks of treatment during follow-up were significant predictors of greater overall time depressed (i.e., averaged across time).
Discussion
This study is unique in following women treated for postpartum depression with psychotherapy and documenting both recurrence for women who recovered with acute treatment and later recovery for women who did not recover with acute treatment. Starting first with the results of the acute trial, 35 (35%) of treated women recovered (HRSD Յ 6), which compares with 19% of depressed pregnant women in an IPT trial (Spinelli & Endicott, 2003) . In the acute trial, 83% of women no longer met criteria for depression compared with 61% for postpartum depressed women followed in Cooper et al.'s (2003) trial. With an HRSD score less than or equal to 7 as the criterion for recovery, our rate of 45% is comparable with recovery rates in other trials of IPT with nonpostpartum women (Frank et al., 2007) . In summary, women in the acute portion of the trial were as successful as or more successful than women in other comparable trials.
Only 20 (20%) of the 99 women recovered with treatment and followed a course of sustained remission through the entire follow-up period; 43% of recovered women experienced a recurrence during the 18-month follow-up, which is comparable with rates reported by Vittengl et al. (2007) and somewhat higher than those observed in the National Institute of Mental Health Treatment of Depression Collaborative Research Program (Shea et al., 1992) . However, in the Treatment of Depression Collaborative Research Program, only 26% of individuals treated with IPT recovered and achieved sustained remission throughout follow-up (Shea et al., 1992) . Figure 3 shows that, overall, women demonstrated a steady decline in proportion of time depressed each month during the follow-up, such that, on average, women were depressed for 30% of the time in the 18th month versus 60% of the time in the first month of the follow-up. The decline appears largely attributable to the high rates of recovery among women who did not achieve sustained remission with acute treatment ( Figure 2B ).
These findings may simply reflect the episodic course of depression, whether or not it is treated (Solomon et al., 2000) , or they may reflect the boost that women received from therapy that accelerated symptomatic improvement over time, whether or not they recovered with acute treatment. These women had been depressed, on average, for 8 months prior to entry in the acute trial, and the women in the WLC showed little improvement during the acute trial (O'Hara et al., 2000) , suggesting that treatment was important in bringing about recovery during the follow-up period. Moreover, additional treatment during the follow-up period was not associated with staying well or recovering. In fact, for women who recovered in the initial trial, treatment in the follow-up was actually a signal for relapse. Nevertheless, without a nontreated control group during the follow-up period, it is not possible to firmly conclude that IPT was responsible for the continuing decline in depressive symptoms following treatment. Moreover, Cooper et al. (2003) did not find a continuing benefit for treated postpartum depressed women, but they provided only cross-1 Time was measured in months since the midpoint between 1 month posttreatment and 18 months posttreatment and was group-mean centered at Level 1 to model the intercept as the overall proportion of time depressed during the follow-up period (Raudenbush & Bryk, 2002) . a There were no significant differences in treatment-seeking, sectional follow-up data and did not chart the courses of recurrence and recovery in their sample. Putting together the findings from the acute trial (O'Hara et al., 2000) and the follow-up, there is little question that there is significant room for improvement in clinical outcomes both with acute treatment and in keeping women well once the depression has remitted. Extending acute treatment in a continuation phase (Hollon et al., 2005; Jarrett et al., 2001) for women who have not achieved stable remission and offering maintenance treatment (Frank et al., 2007) to women who have achieved stable remission are established approaches with nonpostpartum women and should be extended to the treatment of postpartum depression. The challenge is in keeping women engaged in treatment for extended periods of time, particularly when they are already trying to balance the responsibilities of infant care with work and family.
Women who went into treatment with more past episodes of depression and ended treatment with higher levels of depression experienced lengthier periods of depression in the follow-up period. Also, women with longer index episodes were slower to improve over the period of the follow-up. These findings once again point to the importance of providing continuation treatment to women who are not likely to continue to improve after acute treatment or to maintain their treatment gains without additional treatment. Similar to the case for other depression treatment trials, the women in this study had few comorbid disorders. Additionally, they were relatively well educated, and all were in a stable partnered relationship at the time they enrolled in the original trial. All of these features were likely to improve outcomes (Szadoczky et al., 2004) . Nevertheless, the naturalistic follow-up and repeated assessments with the LIFE interview allowed for the documentation of both recurrence and recovery following acute treatment in a postpartum depressed sample, which represent unique contributions of this study.
